MX2021014546A - Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales. - Google Patents

Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales.

Info

Publication number
MX2021014546A
MX2021014546A MX2021014546A MX2021014546A MX2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A MX 2021014546 A MX2021014546 A MX 2021014546A
Authority
MX
Mexico
Prior art keywords
neuronal
hydroxybutyrate
beta
transient ischemic
ischemic attacks
Prior art date
Application number
MX2021014546A
Other languages
English (en)
Inventor
Sami Hashim
Original Assignee
Neuroenergy Ventures Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuroenergy Ventures Inc filed Critical Neuroenergy Ventures Inc
Publication of MX2021014546A publication Critical patent/MX2021014546A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Un método de uso del Tris (Beta-hidroxibutirato) de glicerilo en la minimización, reducción o prevención del déficit neuronal y/o muerte de células neuronales con respecto a los ataques isquémicos transitorios neuronales (NTIA) de seguimiento en sujetos que tuvieron (o en sujetos que presentan sintomatología de haber tenido) al menos un NTIA previo.
MX2021014546A 2019-05-30 2019-05-30 Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales. MX2021014546A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2019/034592 WO2020242478A1 (en) 2019-05-30 2019-05-30 Glyceryl tris (beta-hydroxybutyrate) and neuronal transient ischemic attacks

Publications (1)

Publication Number Publication Date
MX2021014546A true MX2021014546A (es) 2022-01-06

Family

ID=73552030

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021014546A MX2021014546A (es) 2019-05-30 2019-05-30 Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales.

Country Status (10)

Country Link
US (1) US20220288006A1 (es)
EP (1) EP3976021A4 (es)
JP (1) JP7403861B2 (es)
KR (1) KR20220016145A (es)
CN (1) CN113710243A (es)
BR (1) BR112021022763A2 (es)
CA (1) CA3136552C (es)
IL (1) IL288343B2 (es)
MX (1) MX2021014546A (es)
WO (1) WO2020242478A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2530753T3 (es) 1997-03-17 2015-03-05 Btg Int Ltd Composiciones terapéuticas que comprenden cuerpos cetónicos y precursores de los mismos
GB0420856D0 (en) 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
CN104224823A (zh) * 2007-03-30 2014-12-24 有限会社爱泽世 生酮作用促进剂组合物
MX2009011002A (es) 2007-04-12 2010-03-15 Univ Minnesota Composiciones de proteccion de isquemia/reperfusion y metodos de uso.
CN105640931A (zh) * 2008-07-03 2016-06-08 艾克塞拉公司 用于治疗神经性障碍的乙酰乙酸的单甘油酯及其衍生物
WO2017011294A1 (en) * 2015-07-10 2017-01-19 Cognate Nutritionals, Inc. Prophylaxis and mitigation of migraine headaches using medium chain triglycerides, ketone esters, and other ketogenic sources
US20180177753A1 (en) * 2016-12-23 2018-06-28 Neuroenergy Ventures, Inc. Glyceryl 3-hydroxybutyrates for migraine symptom management
US9925164B1 (en) * 2017-01-12 2018-03-27 Neuroenergy Ventures, Inc. Glyceryl 3-hydroxybutyrates for traumatic brain injury

Also Published As

Publication number Publication date
EP3976021A1 (en) 2022-04-06
CA3136552A1 (en) 2020-12-03
US20220288006A1 (en) 2022-09-15
IL288343B1 (en) 2023-12-01
WO2020242478A1 (en) 2020-12-03
KR20220016145A (ko) 2022-02-08
JP2022537487A (ja) 2022-08-26
IL288343B2 (en) 2024-04-01
JP7403861B2 (ja) 2023-12-25
EP3976021A4 (en) 2022-11-09
IL288343A (en) 2022-07-01
CA3136552C (en) 2024-01-16
CN113710243A (zh) 2021-11-26
BR112021022763A2 (pt) 2022-01-11

Similar Documents

Publication Publication Date Title
CO2018003168A2 (es) Moduladores de la expresión de kras
BR112018003102A2 (pt) garras para dissecção cirúrgica
MX2022001018A (es) Electrodos metalicos de bajo costo.
WO2018213661A3 (en) PASSIVATION AGENTS FOR ELECTROCHEMICAL CELLS
BR112018001870A2 (pt) fixador rosqueado.
DOP2021000044A (es) Moduladores de la expresión de pnpla3
BR112018074283A2 (pt) composição e métodos para terapia com microbiota.
BR112018007384A2 (pt) redução da sensação pungente na pele
BR112015016120A8 (pt) dispositivo de suporte e conjuntos
PH12019502174A1 (en) Modulators of pcsk9 expression
MY187277A (en) Load compensator having tension spring assemblies contained in a tubular housing
WO2017021855A3 (en) Motile sperm domain containing protein 2 and inflammation
MX2021014546A (es) Tris (beta-hidroxibutirato) de glicerilo y ataques isquemicos transitorios neuronales.
PH12021551435A1 (en) Triple combination therapies for anti-aging
CL2021001246A1 (es) Moduladores de expresión irf5.
MX2022001898A (es) Metodos para el tratamiento de enfermedades asociadas a la senescencia.
WO2016130498A8 (en) Isolated mucins and different microorganisms, and methods of use
BR112018014171A2 (pt) composições biofotônicas para o tratamento de otite externa
CL2020003346A1 (es) Métodos para tratar la pérdida de la audición y/o pérdida de la visión asociadas con clrn1
EP3743630A4 (en) CORROSION RESISTANT BEARING ELEMENTS, BEARING ASSEMBLIES, BEARING UNITS, AND MOTOR ASSEMBLIES USING THESE
EP3692936A4 (en) STEEL LOCKING PLATE AND STEEL LOCKING PLATE ASSEMBLY INCLUDING IT
BR112019023979A2 (pt) compostos, composições e métodos
López A Chicana's Look at the International Women's Year Conference
Okhrin et al. Erratum to: Copulae in high dimensions: An introduction
Lee Study on the Fire Safety Performance Beyond Measures of School Facilities